What is the approved anticoagulation for the pediatric population?
What is the approved anticoagulation for the pediatric population? The U.S. Food and Drug Administration today approved Fragmin (dalteparin sodium) injection, for subcutaneous use, to reduce the recurrence of symptomatic venous thromboembolism (VTE) in pediatric patients one month of age and older. How do you treat VTE in children? Anticoagulants, primarily low-molecular-weight heparin and warfarin, are used to treat children with symptomatic VTE. These drugs have significant limitations, including the need for subcutaneous injections and frequent monitoring. How long should a pediatric patient receive anticoagulation for a provoked DVT or PE? The American College of Chest Physicians' (ACCP's) adult and...